Drtech Corp (214680) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Drtech Corp (214680:KRX), powered by AI.

Current Price
₩1,293
P/E Ratio
-4.5
Market Cap
107.9B
Sector
Healthcare
What is the Drtech Corp stock price forecast?

Drtech Corp is currently trading at ₩1,293. View real-time AI analysis on Alpha Lenz.

What is Drtech Corp insider trading activity?

View the latest insider trading data for Drtech Corp on Alpha Lenz.

What is Drtech Corp's P/E ratio?

Drtech Corp's P/E ratio is -4.5.

Drtech Corp

KRX · 214680
₩1,293+12(+0.94%)Market closedKRX regular session 09:00–15:30 KST
Ask about Drtech Corp's future dividend policy...
Alpha Chat Insight

Drtech Corp trades at a P/E of -4.5 (undervalued) with modest ROE of -32.1%.

Ask for details

Company Overview

Drtech Corp, a pioneer in technological advancements, primarily specializes in manufacturing and distributing state-of-the-art medical imaging products. As a vital player in the healthcare technology sector, the company's primary function involves developing innovative digital radiography (DR) solutions pivotal for enhancing diagnostic precision and workflow efficiency in medical facilities. Drtech Corp's offerings significantly impact both the public and private healthcare sectors, facilitating the early detection and treatment of medical conditions through cutting-edge imaging technology. Their products are utilized in hospitals, diagnostic centers, and clinics worldwide, reflecting their commitment to improving health outcomes through superior imaging clarity. The company is recognized for its continuous contribution to healthcare innovation, aiding in advancing global medical standards. With a focus on R&D and quality enhancement, Drtech Corp plays a crucial role in the intersection of technology and healthcare, providing essential tools for medical professionals and radiologists. Founded in South Korea, Drtech Corp remains a key component in the global health infrastructure, offering solutions that not only support effective diagnosis but also drive forward the capabilities of modern medicine.

CEO안성현
SectorHealthcare
IndustryMedical Devices
Employees363

Company Statistics

FY 2025

Profile

₩107,935,833,408Market Cap
₩116,304,065,580Revenue
83.48MShares Out
363Employees

Margins

36.10%Gross
-4.00%EBITDA
-11.95%Operating
-22.09%Pre-Tax
-20.66%Net

Valuation

-4.49P/E
1.41P/B
0.93EV/Sales
-37.71EV/EBITDA
-4.01P/FCF

Growth (CAGR)

9.13%Rev 3Yr
16.04%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-12.61%ROA
-32.14%ROE
-9.29%ROIC

Financial Health

₩21,179,675,800Cash & Cash Equivalents
₩103,934,337,110Net Debt
162.98%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Drtech Corp (ticker: 214680) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 363 employees. Market cap is $107.9B.

The current price is ₩1,293 with a P/E ratio of -4.49x and P/B of 1.41x.

ROE is -32.14% and operating margin is -11.95%. Annual revenue is $116.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Drtech Corp (214680) Stock Forecast 2026 ₩1,293 — Price, Financials & Analyst Targets | Alpha Lenz